SCHEMBL5669774

SCHEMBL5669774

CCOC(=O)c1csc(CC(NC(=O)COc2ccc(OC(F)(F)F)cc2)c2ccccc2)n1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.47
MAPT P10636 5/20 0.47
NPC1 O15118 4/20 0.47
HSP90AA1 P07900 2/20 0.47
MMP13 P45452 6/20 0.46
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MAPK1 P28482 1/20 0.43
GAA P10253 2/20 0.42
LMNA P02545 1/20 0.42
MMP1 P03956 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
ATM Q13315 1/20 0.40
PDE2A O00408 1/20 0.40
PLA2G4A P47712 1/20 0.40
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5669919 0.90 MMP13 (0.43) MAPTMMP13ALDH1A1LMNAMMP1
SCHEMBL2174194 0.84 PTPRB (0.51) RAB9AMAPTNPC1HSP90AA1MMP13
SCHEMBL2174676 0.80 MAPT (0.48) RAB9AMAPTNPC1HSP90AA1ALDH1A1
SCHEMBL5668327 0.79 RAB9A (0.53) RAB9AMAPTNPC1HSP90AA1MMP13
SCHEMBL18003076 0.77 MAPT (0.76) RAB9AMAPTNPC1HSP90AA1MMP13
SCHEMBL2172774 0.74 PTPN1 (0.46) ALDH1A1LMNACYP1A2CYP2C19
SCHEMBL4562630 0.73 SMN1; SMN2 (0.42) MMP13ALDH1A1SMN1; SMN2MMP1CYP1A2
SCHEMBL15349050 0.73 RAB9A (0.55) RAB9AMAPTNPC1HSP90AA1MMP13
SCHEMBL4383724 0.72 ALDH1A1 (0.43) MAPTALDH1A1SMN1; SMN2GAACYP1A2
SCHEMBL4392406 0.72 ALDH1A1 (0.43) MAPTALDH1A1SMN1; SMN2GAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730128-A1 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE Exelixis, Inc. (US) 2006-12-13 EP disclosed
WO-2005097765-A1 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE EXELIXIS, INC. (US) 2005-10-20 WO disclosed